Showing results (301-310 of 357) with videos related to
Sort By:
Pageof 36
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2021
d-mannose suppresses oxidative response and blocks phagocytosis in experimental neuroinflammationJing Wang, Negin Jalali Motlagh, Cuihua Wang, et al.Organic & Biomolecular Chemistry|January 9, 2015
Synthesis, binding affinity and structure-activity relationships of novel, selective and dual targeting CCR2 and CCR5 receptor antagonistsAnna Junker, Artur K Kokornaczyk, Annelien J M Zweemer, et al.Therapeutic Advances in Cardiovascular Disease|August 1, 2019
Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndromeLiping Zhang, Xiaoyu Yan, Partha Nandy, et al.Journal of Thrombosis and Thrombolysis|April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolismAlexander Solms, Stefan Willmann, Isabel Reinecke, et al.Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
High-Throughput Screening for Prescribing Cascades Among Real-World Angiotensin-II Receptor Blockers (ARBs) InitiatorsAsinamai M Ndai, Kayla Smith, Shailina Keshwani, et al.Clinical Pharmacology and Therapeutics|June 20, 2022
Development of a Translational Exposure-Bracketing Approach to Streamline the Development of Hormonal Contraceptive Drug ProductsBrian Cicali, Lais Da Silva, Amir Sarayani, et al.Antimicrobial Agents and Chemotherapy|November 17, 2020
The Funnel: a Screening Technique for Identifying Optimal Two-Drug Combination Chemotherapy RegimensG L Drusano, Sarah Kim, Mohammed Almoslem, et al.International Journal of Antimicrobial Agents|December 27, 2021
Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolidSarah Kim, Arnold Louie, George L Drusano, et al.Journal of Thrombosis and Thrombolysis|April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolismIsabel Reinecke, Alexander Solms, Stefan Willmann, et al.Journal of Thrombosis and Thrombolysis|April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillationLiping Zhang, Xiaoyu Yan, Keith A A Fox, et al.Pageof 36